Glucose Biosensor Market Report 2022: Growing Demand for Self-Monitoring Devices Drives 14.45% YoY Growth –

DUBLIN–(BUSINESS WIRE)–The report “Analysis of the Glucose Biosensors Market, by Technology, by Product, by End Users and by Region – Global Forecast to 2029” has been added to from offer.

The market size of Glucose Biosensors is estimated to be USD 13,200 Million in 2021 and is expected to witness a CAGR of 14.45% during the forecast period 2022-2029. Rising global demand for self-monitoring devices, modernizations in glucose biosensor technology, and an increasing proportion of people worldwide developing diabetes are some of the major market drivers. However, the strict regulatory framework and high price of glucose biosensors are expected to restrain the market growth.

Regional markets

In 2021, North America held the largest market share owing to growing elderly population, growing prevalence of diabetes in the region, growing demand for remote and home monitoring, increased incidence diabetes caused by lifestyle changes and technological improvements.

However, the Asia-Pacific region is expected to grow at the fastest rate over the projection period due to growing public understanding of the benefits of early diagnosis to increase patient survival rates, rising incomes, accessibility of sophisticated glucose biosensors from a variety of vendors, and improvements to healthcare facilities and payment procedures.

Segmentation: Glucose Biosensor Market Analysis Report 2021-2029

Technology (Revenue, USD million)

  • Optical biosensors

  • Electrochemical biosensors

Product (Revenue, Million USD)

  • Self-monitoring of blood glucose (SMBG)

  • Continuous Glucose Monitoring (CGM)

End User (Revenue, USD Million)

  • Home Care

  • Hospitals

  • Diagnostic centers and clinics

  • Others

By Region (Revenue, USD Million)

North America


  • Germany

  • France

  • UK

  • Spain

  • Italy

  • The rest of Europe

Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of APAC

Latin America

  • Brazil

  • Mexico

  • Argentina

  • Rest of LATAM

Middle East and Africa

  • South Africa

  • GCC

  • Rest of MEA

Main topics covered:

1. Research methodology

2. Introduction: glucose biosensors

3. Executive Summary

4. Market dynamics

5. Analysis of the market environment

6. COVID-19 Impact Analysis: Glucose Biosensor Market

7. Market Analysis by Technology

8. Market Analysis by Product

9. Market Analysis by End User

10. Regional Market Analysis

11. North America Glucose Biosensor Market

12. Europe Glucose Biosensor Market

13. Asia Pacific Glucose Biosensor Market

14. Latin America Glucose Biosensor Market

15. MEA Glucose Biosensor Market

16. Competitor Analysis

17. Company Profiles

18. Conclusion

19. Recommendations

Companies cited

  • Trividia Health (US)

  • Sanofi (France)

  • Nova Diabetes Care (USA)

  • Lifescan (US)

  • GlySens Incorporated (USA)

  • F. Hoffmann-La Roche SA (Switzerland)

  • Dexcom (USA)

  • Bayer (Germany)

  • Ascenia Diabetes Care (Switzerland)

  • Abbott Laboratories (USA)

For more information about this report visit

About William G.

Check Also

Wastewater Reclamation Systems Market Analysis and Forecast

Wastewater Reclamation Systems Market The study provides logical insights as well as historical and forecast …